MDxHealth Statistics
Total Valuation
MDxHealth has a market cap or net worth of $27.89 million. The enterprise value is $90.62 million.
| Market Cap | 27.89M |
| Enterprise Value | 90.62M |
Important Dates
The next estimated earnings date is Tuesday, August 4, 2026, after market close.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MDxHealth has 51.36 million shares outstanding. The number of shares has increased by 33.51% in one year.
| Current Share Class | 51.36M |
| Shares Outstanding | 51.36M |
| Shares Change (YoY) | +33.51% |
| Shares Change (QoQ) | -0.68% |
| Owned by Insiders (%) | 6.46% |
| Owned by Institutions (%) | 30.05% |
| Float | 35.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.25 |
| Forward PS | 0.25 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.82 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.63
| Current Ratio | 1.63 |
| Quick Ratio | 1.38 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.11 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -6.38% |
| Return on Invested Capital (ROIC) | -12.19% |
| Return on Capital Employed (ROCE) | -14.36% |
| Weighted Average Cost of Capital (WACC) | -581,154.87% |
| Revenue Per Employee | $304,860 |
| Profits Per Employee | -$91,146 |
| Employee Count | 364 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 7.52 |
Taxes
| Income Tax | -1.99M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -72.44% in the last 52 weeks. The beta is -506,809.90, so MDxHealth's price volatility has been lower than the market average.
| Beta (5Y) | -506,809.90 |
| 52-Week Price Change | -72.44% |
| 50-Day Moving Average | 1.39 |
| 200-Day Moving Average | 3.10 |
| Relative Strength Index (RSI) | 21.38 |
| Average Volume (20 Days) | 760,140 |
Short Selling Information
The latest short interest is 457,830, so 1.18% of the outstanding shares have been sold short.
| Short Interest | 457,830 |
| Short Previous Month | 910,289 |
| Short % of Shares Out | 1.18% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.40 |
Income Statement
In the last 12 months, MDxHealth had revenue of $110.97 million and -$33.18 million in losses. Loss per share was -$0.65.
| Revenue | 110.97M |
| Gross Profit | 70.74M |
| Operating Income | -17.12M |
| Pretax Income | -35.17M |
| Net Income | -33.18M |
| EBITDA | -10.72M |
| EBIT | -17.12M |
| Loss Per Share | -$0.65 |
Balance Sheet
The company has $43.15 million in cash and $105.88 million in debt, with a net cash position of -$62.73 million or -$1.22 per share.
| Cash & Cash Equivalents | 43.15M |
| Total Debt | 105.88M |
| Net Cash | -62.73M |
| Net Cash Per Share | -$1.22 |
| Equity (Book Value) | -20.23M |
| Book Value Per Share | -0.39 |
| Working Capital | 26.32M |
Cash Flow
In the last 12 months, operating cash flow was -$1.05 million and capital expenditures -$1.04 million, giving a free cash flow of -$2.09 million.
| Operating Cash Flow | -1.05M |
| Capital Expenditures | -1.04M |
| Depreciation & Amortization | 6.40M |
| Net Borrowing | 16.74M |
| Free Cash Flow | -2.09M |
| FCF Per Share | -$0.04 |
Margins
Gross margin is 63.75%, with operating and profit margins of -15.43% and -29.90%.
| Gross Margin | 63.75% |
| Operating Margin | -15.43% |
| Pretax Margin | -31.69% |
| Profit Margin | -29.90% |
| EBITDA Margin | -9.66% |
| EBIT Margin | -15.43% |
| FCF Margin | n/a |
Dividends & Yields
MDxHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -33.51% |
| Shareholder Yield | -33.51% |
| Earnings Yield | -118.95% |
| FCF Yield | -7.50% |
Analyst Forecast
The average price target for MDxHealth is $2.90, which is 434.07% higher than the current price. The consensus rating is "Buy".
| Price Target | $2.90 |
| Price Target Difference | 434.07% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 8.42% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 14, 2023. It was a reverse split with a ratio of 1:10.
| Last Split Date | Nov 14, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
MDxHealth has an Altman Z-Score of -2.54 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.54 |
| Piotroski F-Score | 3 |